GLUTAMAC (L-Glutamine) is used to provide protection to
cancer patients suffering from glutamine deficiency as a result
of physiologic stress produced by the disease as well as the
toxic effects of cancer treatment involving chemotherapy and
radiation
Optimize cancer treatment by ensuring administration of
recommended doses of chemotherapy and/or radiation without the
need for dose reductions
ZOLEGET (Zoledronic Acid) is used for the treatment of -
Hypercalcemia of malignancy and for treatment of bone
metastases in patients with multiple myeloma and solid tumors in
conjunction with antineoplastic therapy. Patients with prostate
cancer should have progressed after therapy with at least one
hormonal agent.
IMAGET (imatinib) is a new molecular targeted therapy for
Chronic Myeloid Leukemia (CML) with the convenience of oral
administration .
IMAGET is the first of a novel class of drugs called
tyrosine kinase inhibitors that showed highest response-rates in
CML patients
IMAGET (Imatinib) is the drug of first-choice in CML due to
its remarkable results in all three phase of CML - Chronic ,
Accelerated and Blast Phases
IMAGET (imatinib) produces 100% hematologic response as well
as 100% cytogentic response (complete absence of the genetically
abnormal Philadelphia chromosome in the nucleus of the white
blood cells)